Biosimilars Offer Potential for Significant Savings for Health Plans
The Self-Insurer • Tue Jul 08 2025
The buzz around biosimilars and their potential for health plan savings has been building since these drugs entered the market in 2015.
The buzz around biosimilars and their potential for health plan savings has been building since these drugs entered the market in 2015.
To read the full article on page 4, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.